High-dose folic acid supplements do not prevent pre-eclampsia in women at high risk for the condition, according to a new study.
Researchers from six countries looked at the prevalence of pre-eclampsia in pregnant women – beyond the first trimester – who were taking 4mg folic acid supplements compared with those who were not, but found no difference.
Related Article: Community nurses call for more ‘GP back-up’ in palliative care decisions
Just under 15% of women in the folic acid group experienced pre-eclampsia (169/1,144), compared to just under 14% (156/1,157) in the placebo group.
The researchers analysed nearly 2,500 pregnant women from across 70 obstetrical centres in five countries – Argentina, Australia, Canada, Jamaica, and the UK – all of whom had at least one high risk factor for pre-eclampsia between 2011 and 2015.
The researchers concluded: ‘Supplementation with 4.0mg per day folic acid beyond the first trimester does not prevent pre-eclampsia in women at high risk for this condition.’
Related Article: All GP practices to be trained in supporting veterans in £1.8m programme
They added: ‘However, folic acid supplementation remains indicated in preconception and early pregnancy but there is a need to define when to discontinue supplementation as current clinical practice guidelines do not provide clear guidance beyond the first trimester.’
In June, researchers conducting a separate study found there is no evidence that vitamin D reduces the likelihood of gestational diabetes and preeclampsia.
Related Article: Action needed on ‘damaging’ school nurse decline to help tackle STI rise
They said their findings supported the World Health Organization’s position that ‘evidence recommending vitamin D supplementation for women during pregnancy to reduce adverse pregnancy outcomes is insufficient’.
